Exercise and inflammation: Scientific analysis of human studies

Summary

This report reviews seven adult human randomized trials that tracked exercise interventions against blood markers linked to chronic, low‑grade inflammation (often termed inflammaging), including C‑reactive protein, interleukin 6, interleukin 8 and tumor necrosis factor alpha.

In older adults, a year‑long moderate activity program lowered interleukin 6 a little versus a health‑education control at month 12 (about 0.21 pg/mL lower; 8.5% difference). C‑reactive protein did not clearly differ.¹
Another year‑long program in similar adults found interleukin 8 about 0.87 pg/mL (9.9%) lower with activity at 12 months; other markers did not change.²
In older adults with extra weight, diet‑plus‑activity for 18 months showed lower high‑sensitivity interleukin 6 at the end (2.1 pg/mL) than activity alone (2.5 pg/mL) or health education (2.4 pg/mL); authors note changes seemed tied mainly to weight loss.³
In obese older women, eight weeks of machine‑based and free‑weight sessions showed lower after‑training C‑reactive protein (7.67 vs 10.54 mg/L), interleukin 6 (4.45 vs 6.10 pg/mL), and tumor necrosis factor alpha (38.0 vs 48.75 pg/mL) than controls; baseline‑to‑end numbers by group were not reported.⁸
In older women, 12 weeks of resistance sessions reduced C‑reactive protein by 28.6% and tumor necrosis factor alpha by 21.6%, while the control group increased by 34.5% and 13.3%, respectively; exact start and end numbers were not reported.⁴
In older adults with type 2 diabetes, adding progressive resistance sessions to weight‑loss treatment did not change most markers over the first six months versus weight‑loss alone; the paper reports larger tumor necrosis factor alpha drops at months 9 and 12 and a rise in adiponectin at month 12 with resistance work (numbers not reported).⁵
In adults with metabolic syndrome under calorie restriction, a comparative look at two trials found low‑volume high‑intensity intervals reduced interleukin 6 more than control and favored changes in other indices; tables show group values at start and after training.⁶

Limits of the evidence: several trials were short (8–12 weeks) or modest in size, a number did not report full start‑to‑end values, and results were mixed across markers and groups. No advice is given here.

Clinical effects by health area

Inflammation markers: healthy or community‑dwelling older adults

Study title: Exercise training and plasma C‑reactive protein and interleukin‑6 in elderly people

Who they were at the start: 424 men and women, ages 70–89, living in the community and at risk for mobility limits.
What they did: 12 months of moderate activity (walking, strength, balance, flexibility), several days each week, center‑based plus home.
What the other group did: Group classes on health and successful aging without added exercise.
Main thing they checked and when: Blood C‑reactive protein and interleukin 6 at 6 and 12 months.
Main result between groups (plain numbers): At month 12, interleukin 6 was about 0.21 pg/mL lower with activity; the control group was 8.5% higher than the activity group. C‑reactive protein did not clearly differ. Start‑to‑end numbers for each group were not reported.
Extra interesting result: A stronger interleukin 6 effect was noted in people who started with worse function or higher interleukin 6.
Why results may differ: Baseline function and starting interleukin 6 may modify effects.
Real‑life meaning (paper’s words, translated): In these older adults, a year of regular movement produced a small decline in interleukin 6; C‑reactive protein did not change clearly.
Quote: “Greater PA results in lower systemic concentrations of IL‑6 in elderly individuals.”¹

Study title: Long‑term physical activity and inflammatory biomarkers in older adults

Who they were at the start: 424 older adults, ages 70–89, living in the community.
What they did: 12 months of moderate activity, several sessions per week.
What the other group did: Health education with no added exercise.
Main thing they checked and when: A panel of blood markers at months 6 and 12.
Main result between groups (plain numbers): At month 12, interleukin 8 was 0.87 pg/mL lower with activity, about 9.9% lower than the other group. Other markers did not change clearly. Start‑to‑end numbers for each group were not reported.
Extra interesting result: People who began with higher interleukin 15 showed a drop with activity; this did not hold after multiple‑test adjustment.
Why results may differ: Not discussed in numbers.
Real‑life meaning: Over a year, only interleukin 8 was lower with activity in this sample.
Quote: “IL‑8 was the only inflammatory biomarker affected by the PA intervention.”²

Inflammation markers: older adults with overweight or obesity

Study title: Independent and combined effects of physical activity and weight loss on inflammatory biomarkers in overweight and obese older adults

Who they were at the start: Men and women aged 60–79 with extra weight and risk for heart problems.
What they did: 18 months of diet‑plus‑activity or activity alone; a third group had health education.
What the other group did: Health education without added exercise or diet change.
Main thing they checked and when: Blood leptin and high‑sensitivity interleukin 6 at 6 and 18 months.
Main result between groups (plain numbers): At 18 months, high‑sensitivity interleukin 6 was 2.1 pg/mL with diet‑plus‑activity vs 2.5 pg/mL with activity alone vs 2.4 pg/mL with health education. Start‑to‑end numbers were not reported.
Extra interesting result: Leptin at 18 months was lower with diet‑plus‑activity (21.3 ng/mL) than both other groups (29.3 and 30.3 ng/mL).
Why results may differ: The authors note weight loss appeared to drive the changes more than activity.
Real‑life meaning: Combining diet with activity showed the lowest interleukin 6 and leptin at end‑point.
Quote: “Results suggest that WL, rather than increased physical activity, is the lifestyle factor primarily responsible for improvement in the inflammatory profile.”³

Study title: Diet‑induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial

Who they were at the start: 316 adults aged 60+ with extra weight and knee osteoarthritis.
What they did: Four groups for 18 months: healthy‑lifestyle classes, diet‑only, exercise‑only (walking plus strength), or diet‑plus‑exercise.
What the other group did: Healthy‑lifestyle classes.
Main thing they checked and when: Blood C‑reactive protein, interleukin 6, and a soluble receptor linked to tumor necrosis factor alpha at several time points.
Main result between groups (plain numbers): Greater reductions in C‑reactive protein, interleukin 6 and the tumor necrosis factor receptor occurred with diet‑based weight loss than with no weight‑loss treatment. Exercise‑only did not change these markers clearly, and adding exercise to diet did not further reduce them. Exact start‑to‑end numbers by group were not reported.
Extra interesting result: Change in the receptor marker tracked with change in weight.
Why results may differ: Weight change appears to be a key driver.
Real‑life meaning: In these older adults with joint disease, weight‑loss treatment reduced key markers of low‑grade inflammation; exercise‑only did not.
Quote: “A dietary intervention designed to elicit weight loss reduces overall inflammation in older, obese persons.”⁷

Inflammation markers: obese older women

Study title: Resistance training improves inflammatory level, lipid and glycemic profiles in obese older women: a randomized controlled trial

Who they were at the start: Thirty‑eight women, mean age ~68, with obesity.
What they did: Eight weeks of supervised resistance sessions, three times per week, using machines and free weights.
What the other group did: No exercise.
Main thing they checked and when: Blood C‑reactive protein, interleukin 6, and tumor necrosis factor alpha after eight weeks.
Main result between groups (plain numbers): After training, C‑reactive protein was 7.67 vs 10.54 mg/L, interleukin 6 4.45 vs 6.10 pg/mL, and tumor necrosis factor alpha 38.0 vs 48.75 pg/mL (training vs control). Start‑to‑end numbers for each group were not reported.
Extra interesting result: Favorable changes in lipid and glycemic measures were also reported with training.
Why results may differ: Not discussed in numbers.
Real‑life meaning: In this short study, women doing resistance sessions had lower after‑training inflammation marker levels than women who did not exercise.
Quote: “These results suggest that 8 weeks of RT promote improvements on inflammatory levels.”⁸

Study title: Resistance training reduces metabolic syndrome and inflammatory markers in older women: a randomized controlled trial

Who they were at the start: Fifty‑three older women (mean age ~70).
What they did: Twelve weeks of supervised resistance sessions.
What the other group did: No exercise.
Main thing they checked and when: Blood C‑reactive protein and tumor necrosis factor alpha after 12 weeks.
Main result between groups (plain numbers): The training group decreased C‑reactive protein by 28.6% and tumor necrosis factor alpha by 21.6%, while the control group increased by 34.5% and 13.3%. Exact start and end numbers were not reported.
Extra interesting result: Improvements were also noted in a metabolic syndrome summary score.
Why results may differ: Not discussed in numbers.
Real‑life meaning: Three months of resistance sessions were linked with lower levels of two common blood markers of low‑grade inflammation.
Quote: “The results suggest that a 12‑week RT program seems to effectively reduce… inflammatory biomarkers in older women.”⁴

Inflammation markers: adults with metabolic syndrome

Study title: “HIIT the Inflammation”: low‑volume interval training versus comparators under caloric restriction

Who they were at the start: Adults with metabolic syndrome undergoing calorie restriction, drawn from two parent exercise trials.
What they did: Low‑volume high‑intensity interval sessions on a bike, several weeks in length.
What the other group did: Either no added exercise, moderate intervals, or resistance sessions, depending on the parent arm.
Main thing they checked and when: Panels including interleukin 6 and other indices at the end of training.
Main result between groups (plain numbers): Interleukin 6 declined more with low‑volume intervals than in control arms; for example, one cohort went from 4.9→3.6 pg/mL versus 4.8→4.5 pg/mL in control. Other panels favored intervals over some comparators in select indices; numbers varied by cohort and marker.
Extra interesting result: Comparisons versus moderate intervals and resistance training showed differing patterns by marker.
Why results may differ: The authors note calorie restriction and starting values may shape changes.
Real‑life meaning: With concurrent calorie restriction, short, hard bike intervals were linked with lower interleukin 6 than comparison arms across cohorts in this sub‑analysis.
Quote: “Low‑HIIT decreased IL‑6… compared to CON and MICT groups.”⁶

Inflammation markers: older adults with type 2 diabetes

Study title: Effects of progressive resistance training and weight loss versus weight loss alone on inflammatory and endothelial biomarkers in older adults with type 2 diabetes

Who they were at the start: Thirty‑six adults aged 60–80 with type 2 diabetes, inactive and overweight.
What they did: Six months of supervised progressive resistance sessions plus weight‑loss support, then six months of home training.
What the other group did: Stretching (sham) plus the same weight‑loss plan.
Main thing they checked and when: Blood interleukin 10, interleukin 6, tumor necrosis factor alpha, adiponectin, resistin, and intercellular adhesion molecule‑1 up to 12 months.
Main result between groups (plain numbers): During the first six months, no clear differences between groups for the inflammation markers. At months 9 and 12, larger tumor necrosis factor alpha drops and a rise in adiponectin with resistance training were reported. Exact start‑to‑end numbers were not reported.
Extra interesting result: Adiponectin was higher after 12 months with resistance work.
Why results may differ: Results were adjusted for medicines and other factors.
Real‑life meaning: Added resistance work did not change most markers early on, but later time points showed some favorable shifts.
Quote: “Long‑term participation in PRT, independent of change in weight, can result in some improvements in certain inflammatory markers.”⁵

Key takeaways on exercise and systemic inflammation

Evidence from randomized trials indicates regular exercise can modestly reduce chronic low‑grade systemic inflammation, including C‑reactive protein and interleukin 6, especially in older adults.
Resistance training and high‑intensity interval training show favorable effects on inflammatory profiles, with additional benefits when paired with weight loss.
Effects are context‑dependent: weight change, baseline inflammation and health status influence changes in inflammatory biomarkers.
Consistent physical activity aligns with improved inflammatory markers and cardiometabolic health in adult populations.

References

· This write‑up only restates what the papers say.

· Methodology: We included adult human randomized trials, prioritizing those published in high‑ranked, peer‑reviewed journals. If fewer than three trials met these criteria, we broadened the journal scope. All numbers and reported side effects are taken directly from the papers. We do not add any conclusions, interpretations or advice.

· This analysis is for general information only. It is not medical advice and does not give personal recommendations or endorsements. Always talk with your healthcare provider before starting any supplement or changing your care. Do not start, stop, or change any medicine because of this text.

Glossary: Full Names and Acronyms (Explained)

The terms below appear in this article. We list the full name first, then the acronym. We explain each in simple, precise language.

C-reactive protein (CRP): A protein your liver makes when your body is inflamed. Higher levels can mean your body is dealing with stress or disease.
Interleukin 6 (IL-6): A signaling protein that helps your immune system respond. It can go up with infection, stress, or chronic conditions.
Interleukin 8 (IL-8): A signaling protein that helps call immune cells to where they are needed. It can be higher when there is ongoing inflammation.
Interleukin 10 (IL-10): A signaling protein that helps calm the immune response. It can help prevent too much inflammation.
Interleukin 15 (IL-15): A signaling protein linked to muscle and immune cell activity. It can change with exercise and training.
Tumor necrosis factor alpha (TNF-α): A strong inflammation signal in the body. High levels are linked to chronic, low-grade inflammation.
Adiponectin: A hormone made by fat tissue that helps control how your body uses sugar and fat. Higher levels are usually a good sign.
Resistin: A hormone that may affect how your body handles sugar and inflammation. Higher levels can be linked to metabolic problems.
Intercellular adhesion molecule-1 (ICAM-1): A protein on cell surfaces that helps immune cells move into tissues. Levels can rise during inflammation.
High-intensity interval training (HIIT): Short bursts of hard exercise with rests in between. It can improve fitness in less time.
Moderate-intensity continuous training (MICT): Steady, moderate exercise done for a set time, like brisk walking or easy cycling.
Control group (CON): The group in a study that does not get the test treatment. It helps researchers see the true effect of the treatment.

These simple definitions are for general information only. They do not replace medical advice.

Source article: Exercise and inflammation: Scientific analysis of human studies.